Karen Eshraghi, MD
Dermatology · Osage Beach, MONPI 1942299326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 32.4% of the total. That places this record below the midpoint for dermatology clinicians in MO, where the typical reported total is $3,173.
Across 75 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$405
- Pfizer$111
- Johnson & Johnson$111
- Amgen$101
- Sanofi$94
- Novartis$92
- plus $336 from 10 others
What the payments were for
- Food & beverage$1,249100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $405 |
| Pfizer | 7 | $111 |
| Johnson & Johnson | 7 | $111 |
| Amgen | 5 | $101 |
| Sanofi | 5 | $94 |
| Novartis | 6 | $92 |
| UCB, Inc. | 3 | $67 |
| Sun Pharmaceutical Industries Inc. | 4 | $61 |
| Galderma Laboratories, L.p. | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Bristol Myers Squibb | 2 | $29 |
| Incyte Corporation | 1 | $28 |
| Almirall LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Mission Pharmacal Company | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
How this compares
$1,249 in reported general payments places this provider in the 25th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 17 | $123,662 |
| Doxycycline Hyclate | 80 | $3,145 |
| Famotidine | 152 | $2,083 |
| Clobetasol Propionate | 30 | $1,463 |
| Dapsone | 22 | $1,299 |
| Metronidazole | 31 | $1,259 |
| Fluocinonide | 30 | $1,041 |
| MethotrexateMethotrexate Sodium | 71 | $1,016 |
| Fluorouracil | 14 | $955 |
| Triamcinolone Acetonide | 158 | $840 |
| Cephalexin | 63 | $670 |
| Clindamycin Phosphate | 23 | $661 |
| Mometasone Furoate | 39 | $614 |
| ValacyclovirValacyclovir Hcl | 16 | $567 |
| Ketoconazole | 34 | $556 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Osage Beach
- John DespainOsage Beach$289K
- Brian KimSaint Louis$861K
- Elaine SiegfriedSaint Louis$856K
- Craig LeonardiSaint Louis$569K
- Jonathan CleaverKirksville$483K
- Mary GeorgeSaint Louis$400K
- David CleaverKirksville$371K
- Christy RaineyBranson$328K
- Charles MoonCape Girardeau$296K
- Duane DilworthSaint Louis$288K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.